Brewin Dolphin Wealth Management’s Boston Scientific BSX Stock Holding History

Brewin Dolphin Wealth Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$11K	Hold	300	–	–	﹤0.01%	279
2022 Q1	$13K	Hold	300	–	–	﹤0.01%	272
2021 Q4	$13K	Hold	300	–	–	﹤0.01%	279
2021 Q3	$13K	Hold	300	–	–	﹤0.01%	286
2021 Q2	$12.8K	Hold	300	–	–	﹤0.01%	288
2021 Q1	$11.6K	Hold	300	–	–	﹤0.01%	285
2020 Q4	$10.8K	Hold	300	–	–	﹤0.01%	245
2020 Q3	$11.5K	Buy	+300	New	+$11.6K	﹤0.01%	229

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Brewin Dolphin Wealth Management's BSX Position: Q2 2022 in Review

Brewin Dolphin Wealth Management held its Boston Scientific (BSX) position steady in Q2 2022 at 300 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #279.

Brewin Dolphin Wealth Management first reported a position in BSX in Q3 2020 and has held it in 8 quarters since. The position peaked at $13K in Q3 2021. 878 funds tracked by Wall St. Rank hold BSX as of Q2 2022.

Brewin Dolphin Wealth Management held 300 shares of Boston Scientific worth $11K as of Q2 2022.
Brewin Dolphin Wealth Management left its Boston Scientific share count unchanged in Q2 2022.
Boston Scientific made up ﹤0.01% of Brewin Dolphin Wealth Management's portfolio in Q2 2022, its #279 holding.
Brewin Dolphin Wealth Management first reported a position in Boston Scientific in Q3 2020 and has held it in 8 quarters since.
Brewin Dolphin Wealth Management's Boston Scientific position peaked at $13K in Q3 2021.
878 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2022.

Based on Brewin Dolphin Wealth Management's 13F filing for Q2 2022, filed 14 Nov 2022.